Exclusive

Publication

Byline

Location

US Patent Issued to Bavarian Nordic on Sept. 29 for "Recombinant modified vaccinia virus (MVA) vaccine against coronavirus disease" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,282, issued on Sept. 29, was assigned to Bavarian Nordic A/S (Hellerup, Denmark). "Recombinant modified vaccinia virus (MVA) vaccine again... Read More


US Patent Issued to Takeda Vaccines on Sept. 29 for "Dengue vaccine unit dose and administration thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,283, issued on Sept. 29, was assigned to Takeda Vaccines Inc. (Cambridge, Mass.). "Dengue vaccine unit dose and administration thereof" wa... Read More


US Patent Issued to REPUBLIC OF KOREA (ANIMAL AND PLANT QUARANTINE AGENCY) on Sept. 29 for "Immune adjuvant and vaccine composition including the same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,284, issued on Sept. 29, was assigned to REPUBLIC OF KOREA (ANIMAL AND PLANT QUARANTINE AGENCY) (Gimcheon-si, South Korea). "Immune adjuva... Read More


US Patent Issued to MONASH UNIVERSITY, PETER MACCALLUM CANCER INSTITUTE on Sept. 29 for "Methods of activating cells via PTP 1B inhibition" (Australian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,285, issued on Sept. 29, was assigned to MONASH UNIVERSITY (Clayton, Australia) and PETER MACCALLUM CANCER INSTITUTE (Melbournd, Australia)... Read More


US Patent Issued to SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES on Sept. 29 for "Long-acting ropivacaine pharmaceutical composition, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,286, issued on Sept. 29, was assigned to SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (Shanghai). "Long-acting ropiva... Read More


US Patent Issued to UCB BIOSCIENCES on Sept. 29 for "Methods for increasing the bioavailability of nucleoside medicinal agents" (California Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,287, issued on Sept. 29, was assigned to UCB BIOSCIENCES INC. (Morrisville, N.C.). "Methods for increasing the bioavailability of nucleosi... Read More


US Patent Issued to GUANGZHOU LIDE BIOMEDICINE TECHNOLOGY on Sept. 29 for "Ionizable cationic lipid analog material and use thereof as drug delivery carrier" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,288, issued on Sept. 29, was assigned to GUANGZHOU LIDE BIOMEDICINE TECHNOLOGY Co. LTD. (Guangzhou, China). "Ionizable cationic lipid anal... Read More


US Patent Issued to JENKEM TECHNOLOGY Co. LTD. (TIANJIN) on Sept. 29 for "Antitumor pharmaceutical composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,289, issued on Sept. 29, was assigned to JENKEM TECHNOLOGY Co. LTD. (TIANJIN) (Tianjin, China). "Antitumor pharmaceutical composition and ... Read More


US Patent Issued to Dyne Therapeutics on Sept. 29 for "Muscle targeting complexes and uses thereof for treating myotonic dystrophy" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,290, issued on Sept. 29, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.). "Muscle targeting complexes and uses thereof for treatin... Read More


US Patent Issued to LONZA SALES on Sept. 29 for "Methods of loading extracellular vesicles" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,291, issued on Sept. 29, was assigned to LONZA SALES AG (Basel, Switzerland). "Methods of loading extracellular vesicles" was invented by ... Read More